Home > Insider Trading > Filing (0001209191-15-028085)

Filing Details

Accession Number:: 0001209191-15-028085
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-20 09:03:55
Reporting Period:: 2015-03-18

Filing Date:: 2015-03-20
Accepted Time:: 2015-03-20 09:03:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1237831	Globus Medical Inc	GMED	Surgical & Medical Instruments & Apparatus (3841)	043744954

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555391	C David Paul	Valley Forge Business Center 2560 General Armistead Avenue Audubon PA 19403	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2015-03-18	1,427,079	$25.00	1,572,921	No	4	S	Direct
Class A Common Stock	Disposition	2015-03-19	494,921	$25.00	1,078,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$4.88	2019-08-06	18,461	18,461	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$11.87	2020-06-16	18,461	18,461	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$10.66	2021-10-27	18,461	18,461	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$15.34	2022-08-29	15,000	15,000	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$13.04	2023-01-24	48,000	48,000	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$23.95	2024-01-23	60,000	60,000	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$24.10	2025-01-20	125,000	125,000	Direct
Class A Common Stock	Class B Common Stock	$0.00		21,444,283	21,444,283	Direct
Class A Common Stock	Class B Common Stock	$0.00		1,562,573	1,562,573	Indirect
Class A Common Stock	Class B Common Stock	$0.00		435,350	435,350	Indirect
Class A Common Stock	Class B Common Stock	$0.00		435,350	435,350	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2019-08-06	18,461	18,461	Direct
2020-06-16	18,461	18,461	Direct
2021-10-27	18,461	18,461	Direct
2022-08-29	15,000	15,000	Direct
2023-01-24	48,000	48,000	Direct
2024-01-23	60,000	60,000	Direct
2025-01-20	125,000	125,000	Direct
	21,444,283	21,444,283	Direct
	1,562,573	1,562,573	Indirect
	435,350	435,350	Indirect
	435,350	435,350	Indirect

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on November 26, 2014.
These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on October 27, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on August 29, 2012, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 24, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 23, 2014, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.
These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.
These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust.